FASTK/FASTKD family is mainly located in mitochondria and consists of RNA-binding proteins (including FASTK, FASTKD1-5), which finely regulate the processing, stability and translation of mitochondrial-encoded mRNA/rRNA, maintaining oxidative phosphorylation (OXPHOS) and cellular energy metabolism homeostasis; inhibition/knockdown will lead to specific mitochondrial RNA degradation, respiratory chain complex defects, ROS accumulation and energy crisis, while activation will maintain mitochondrial function. This family targets mitochondrial mRNA such as ND6 and COX3, as well as 16S rRNA, and mainly participates in mitochondrial RNA metabolism and the Fas apoptosis pathway.
Its abnormal expression is associated with mitochondrial diseases such as Leigh syndrome, hypertrophic cardiomyopathy, as well as tumors like lung cancer and pancreatic cancer (energy metabolism reprogramming); currently, it is mainly used in the research of disease biomarkers or metabolic intervention targets. Popular directions include the specific functional roles of members, RNA binding mechanisms, the role of tumor metabolism and immunity, as well as the development of targeted regulators such as PROTAC.
FASTK Human Pre-designed siRNA Set A 包含针对 FASTK (Human) 基因不同区域设计的三对 siRNA,以及阴性对照、FAM 标记阴性对照和阳性对照。
β-Patchoulene 是一种具有口服活性的抗炎、抗氧化及抗凋亡 (apoptosis) 剂,可抑制 NF-κB、TLR4 和 cAMP/PKA/CREB 信号通路,激活 Sirt1/Nrf2 以及 AMPK 信号通路,并抑制 Fas/FasL、Caspase-3、ERK1/2、ROCK1/MLC2 等作用靶点,同时可调节细胞因子分泌、炎性细胞浸润、脂质过氧化、细胞极化、肠道菌群及脂质代谢,恢复屏障功能、线粒体功能与细胞活力,并对甜菜夜蛾幼虫具有驱避活性,因此可用于多种炎症性、缺血性、纤维化相关疾病以及肝细胞癌的相关研究。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号